Literature DB >> 11309303

Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies.

G M Yousef1, A Magklara, A Chang, K Jung, D Katsaros, E P Diamandis.   

Abstract

Kallikreins (KLKs) belong to the serine protease family of proteolytic enzymes. Human pancreatic/renal KLK (KLK1) encodes for an enzyme that is involved in posttranslational processing of polypeptide precursors. The function of the other members of this gene family is currently unknown, but growing evidence suggests that many KLKs are implicated in carcinogenesis. By using the positional candidate approach, we were able to identify a new human KLK-like gene, KLK14 (also known as KLK-L6). This new gene maps to chromosome 19q13.3-q13.4 and is formed of seven exons (two untranslated and five coding exons) and six intervening introns. KLK14 was defined as a KLK gene based on structural and mapping criteria, in relation to other known KLK genes. KLK14 is expressed in a variety of tissues, but the highest levels of KLK14 are found in the central nervous system, including brain, cerebellum, and spinal cord. Our preliminary results show that KLK14 is down-regulated, at the mRNA level, in breast, testicular, prostatic, and ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309303

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Genome-wide gene expression profiling of tongue squamous cell carcinoma by RNA-seq.

Authors:  Hai Xia Zhang; Ou Sheng Liu; Chao Deng; Yan He; Ye Qian Feng; Jin An Ma; Chun Hong Hu; Zhan Gui Tang
Journal:  Clin Oral Investig       Date:  2017-03-29       Impact factor: 3.573

2.  Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.

Authors:  Larissa Dettmar; Nancy Ahmed; Matthias Kotzsch; Sandra Diersch; Rudolf Napieralski; Dalila Darmoul; Manfred Schmitt; Wilko Weichert; Marion Kiechle; Julia Dorn; Viktor Magdolen
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-15       Impact factor: 4.553

3.  The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.

Authors:  G M Yousef; A Scorilas; A Magklara; N Memari; R Ponzone; P Sismondi; N Biglia; M Abd Ellatif; E P Diamandis
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

4.  Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.

Authors:  G M Yousef; C A Borgoño; A Scorilas; R Ponzone; N Biglia; L Iskander; M-E Polymeris; R Roagna; P Sismondi; E P Diamandis
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

5.  Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status.

Authors:  F Fritzsche; T Gansukh; C A Borgoño; M Burkhardt; S Pahl; E Mayordomo; K-J Winzer; W Weichert; C Denkert; K Jung; C Stephan; M Dietel; E P Diamandis; E Dahl; G Kristiansen
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

6.  Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer.

Authors:  A Chang; G M Yousef; A Scorilas; L Grass; P Sismondi; R Ponzone; E P Diamandis
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

7.  Transmembrane serine protease TADG-15 (ST14/Matriptase/MT-SP1): expression and prognostic value in ovarian cancer.

Authors:  H Tanimoto; K Shigemasa; X Tian; L Gu; J B Beard; T Sawasaki; T J O'Brien
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

8.  Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits.

Authors:  Henrik Karring; Ebbe Toftgaard Poulsen; Kasper Runager; Ida B Thøgersen; Gordon K Klintworth; Peter Højrup; Jan J Enghild
Journal:  Mol Vis       Date:  2013-04-12       Impact factor: 2.367

9.  Kallikrein gene downregulation in breast cancer.

Authors:  G M Yousef; G M Yacoub; M-E Polymeris; C Popalis; A Soosaipillai; E P Diamandis
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

Review 10.  Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies.

Authors:  Manfred Schmitt; Viktor Magdolen; Feng Yang; Marion Kiechle; Jane Bayani; George M Yousef; Andreas Scorilas; Eleftherios P Diamandis; Julia Dorn
Journal:  Radiol Oncol       Date:  2013-10-08       Impact factor: 2.991

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.